128 related articles for article (PubMed ID: 9171160)
21. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
[TBL] [Abstract][Full Text] [Related]
22. Influence of mesostriatal afferents on the development and transmitter regulation of intrastriatal grafts derived from embryonic striatal primordia.
Liu FC; Dunnett SB; Graybiel AM
J Neurosci; 1992 Nov; 12(11):4281-97. PubMed ID: 1279138
[TBL] [Abstract][Full Text] [Related]
23. Host afferents into intrastriatal transplants of fetal ventral mesencephalon.
Doucet G; Murata Y; Brundin P; Bosler O; Mons N; Geffard M; Ouimet CC; Björklund A
Exp Neurol; 1989 Oct; 106(1):1-19. PubMed ID: 2477271
[TBL] [Abstract][Full Text] [Related]
24. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats.
Wang Y; Tien LT; Lapchak PA; Hoffer BJ
Cell Tissue Res; 1996 Nov; 286(2):225-33. PubMed ID: 8854891
[TBL] [Abstract][Full Text] [Related]
25. Early specification of striatal projection neurons and interneuronal subtypes in the lateral and medial ganglionic eminence.
Olsson M; Björklund A; Campbell K
Neuroscience; 1998 Jun; 84(3):867-76. PubMed ID: 9579790
[TBL] [Abstract][Full Text] [Related]
26. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.
Granholm AC; Mott JL; Bowenkamp K; Eken S; Henry S; Hoffer BJ; Lapchak PA; Palmer MR; van Horne C; Gerhardt GA
Exp Brain Res; 1997 Aug; 116(1):29-38. PubMed ID: 9305812
[TBL] [Abstract][Full Text] [Related]
27. Comparison between normal developing striatum and developing striatal grafts using drug-induced Fos expression and neuron-specific enolase immunohistochemistry.
Labandeira-Garcia JL; Tobio JP; Guerra MJ
Neuroscience; 1994 May; 60(2):399-415. PubMed ID: 7915411
[TBL] [Abstract][Full Text] [Related]
28. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway.
Nikkhah G; Cunningham MG; Cenci MA; McKay RD; Björklund A
J Neurosci; 1995 May; 15(5 Pt 1):3548-61. PubMed ID: 7538563
[TBL] [Abstract][Full Text] [Related]
29. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
Espejo M; Cutillas B; Arenas TE; Ambrosio S
Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
[TBL] [Abstract][Full Text] [Related]
30. The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: neural transplantation and developmental evidence.
Deacon TW; Pakzaban P; Isacson O
Brain Res; 1994 Dec; 668(1-2):211-9. PubMed ID: 7704606
[TBL] [Abstract][Full Text] [Related]
31. Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern.
Björklund L; Strömberg I
Exp Brain Res; 1997 Jan; 113(1):13-23. PubMed ID: 9028771
[TBL] [Abstract][Full Text] [Related]
32. Intrastriatal grafting of dopamine-containing neuronal cell suspensions: effects of mixing with target or non-target cells.
Brundin P; Isacson O; Gage FH; Björklund A
Brain Res; 1986 Jan; 389(1-2):77-84. PubMed ID: 3081240
[TBL] [Abstract][Full Text] [Related]
33. Repeated administration of a selective dopamine D2 receptor agonist to 6-OHDA-lesioned rats does not affect the survival and outgrowth of intrastriatal fetal mesencephalic grafts.
Van Muiswinkel FL; Bol JG; Ruijter JM; Stoof JC; Drukarch B; Steinbusch HW
Exp Brain Res; 1995; 107(1):52-8. PubMed ID: 8751062
[TBL] [Abstract][Full Text] [Related]
34. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants.
Winkler C; Bentlage C; Nikkhah G; Samii M; Björklund A
Exp Neurol; 1999 Feb; 155(2):165-86. PubMed ID: 10072293
[TBL] [Abstract][Full Text] [Related]
35. Host dopaminergic afferents affect the development of DARPP-32 immunoreactivity in transplanted embryonic striatal neurons.
Defontaines B; Peschanski M; Onteniente B
Neuroscience; 1992 Jun; 48(4):857-69. PubMed ID: 1352865
[TBL] [Abstract][Full Text] [Related]
36. Embryonic mesencephalic and striatal co-grafts: development of grafted dopamine neurons and functional recovery.
Yurek DM; Collier TJ; Sladek JR
Exp Neurol; 1990 Aug; 109(2):191-9. PubMed ID: 2379555
[TBL] [Abstract][Full Text] [Related]
37. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Strömberg I; Kehr J; Andbjer B; Fuxe K
Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
[TBL] [Abstract][Full Text] [Related]
38. Fos expression in intrastriatal striatal grafts: regulation by host dopaminergic afferents.
Mandel RJ; Wictorin K; Cenci MA; Björklund A
Brain Res; 1992 Jun; 583(1-2):207-15. PubMed ID: 1504828
[TBL] [Abstract][Full Text] [Related]
39. Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalon cells.
Moukhles H; Nieoullon A; Daszuta A
Neuroscience; 1992; 47(4):781-92. PubMed ID: 1349734
[TBL] [Abstract][Full Text] [Related]
40. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons.
Di Loreto S; Florio T; Capozzo A; Napolitano A; Adorno D; Scarnati E
Exp Neurol; 1996 Apr; 138(2):318-26. PubMed ID: 8620930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
